XRCC2 and ovarian carcinoma: For example, in ovarian cancer, MRPL15 (mitochondrial ribosomal protein 15) is suggested as a prognostic indicator and therapeutic target [39], or XRCC2 repairing mtDNA damage in hepatocellular carcinoma [40].